Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06474026 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bilateral Nucleus Accumbens Focused Ultrasound Neuromodulation for Stimulant Use Disorder

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jul 31, 2026 → Jul 31, 2027
See other at-risk trials from Korea University Anam Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 31, 2026 to Jul 31, 2027v4 Show 5 more changesShow less
    • Enrollment increased: 10 → 15 participants
    • Trial arms changed: 2 → 1
    • Secondary endpoints revised (5)
    • Study title shortened, about 12 words
    • Study description expanded, about 4 words
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Primary completion date: Oct 1, 2024 to Jul 31, 2026
    • Study completion date: Jul 31, 2025 to Jul 31, 2026
    • Start date changed from estimate of Aug 1, 2024 to Jul 1, 2024
    • Eligibility criteria shortened, about 5 words
    • Study description shortened, about 4 words
    • Study title shortened, about 4 words
  3. Secondary endpoints revised (5)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psychostimulant use disorder (PUD).
Trial Details
NCT Number NCT06474026
Lead Sponsor Korea University Anam Hospital
Conditions
(from sponsor)		 Psychostimulant Use Disorder(PUD)
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov